产品信息
抗原名称
RNA-dependent RNA polymerase
商品描述
Favipiravir (T-705) is a potent and selective RNA-dependent RNA polymerase inhibitor, used to treat influenza virus infections.
分子量
157.1
纯度
>98%
可溶性
DMSO : 29 mg/mL (184.6 mM)
Ethanol : 12 mg/mL (76.4 mM)
Water : 5 mg/mL (31.82 mM), warmed
Ethanol : 12 mg/mL (76.4 mM)
Water : 5 mg/mL (31.82 mM), warmed
外观
yellow Powder
In vitro(体外研究)
Favipiravir shows anti-influenza virus activities with IC50 ranged from 0.013 to 0.48 μg/ml for the influenza A viruses, from 0.039 to 0.089 μg/ml for the influenza B viruses, and from 0.030 to 0.057 μg/ml for the influenza C viruses. In mammalian cell lines (MDCK cells, Vero cells, HEL cells, A549 cells, HeLa cells, and HEp-2 cells), Favipiravir shows no cytotoxicity at concentrations up to 1,000 μg/ml. In MDCK cells inoculated with seasonal influenza A (H1N1) viruses, Favipiravir induces lethal mutagenesis.
In vivo(体内研究)
In influenza virus-infected mice, Favipiravir (200 mg/kg/day, p.o.) protects the mice from death from influenza virus infection. In mice experimentally infected with Ebola virus, Favipiravir efficiently blocks viral production, reaching an antiviral effectiveness of 95% and 99.6% at 2 and 6days after initiation of treatment, respectively.
背景
别名
法匹拉韦；T 705；Favipiravir；T705
分子式
C5H4FN3O2
CAS号
259793-96-9
制备和贮存
保存方式
Store at -20℃ for one year（Powder）；Store at 2-4℃ for two weeks；Store at -20℃ for six months after dissolution.
参考图片
本文来自投稿，不代表本人立场，如若转载，请注明出处：http://www.iamyjet.com/article/19729.html